Curesponse and Rafael announce collaboration

GlobeNewswire

Curesponse and Rafael to collaborate on integrating Artificial Intelligence capabilities in precision oncology platform. This collaboration combines Rafael’s vast array of combat-proven AI and Machine Learning capabilities with Curesponse’s cutting-edge, personalized oncology technologies in the fields of Drug Response, the Tumor Microenvironment (TME), and Molecular Biology to bring a unique, accurate and combined Genomic-Functional drug […]

Curesponse shows applicability with next generation immuno-oncology drugs

Curesponse’s poster presented at the recent ESMO Immuno-Oncology Congress in Geneva showed the cResponse™ platform can be applied for the modeling and evaluation of immune modulating drugs in cancer tissue.The cResponse™ assay maintains the high viability of human cancer, uniquely preserving the 3D architecture together with its microenvironment, including immune cells for sufficient time to […]